Global Heart Pump Devices Market to Reach $7.6 Billion by 2030
The global market for Heart Pump Devices estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$7.6 Billion by 2030, growing at a CAGR of 17.8% over the analysis period 2022-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is projected to record a 19.6% CAGR and reach US$4.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Intra-aortic Balloon Pumps (IABPs) segment is readjusted to a revised 15% CAGR for the next 8-year period.The U.S. Market is Estimated at $596 Million, While China is Forecast to Grow at 16.9% CAGR
The Heart Pump Devices market in the U.S. is estimated at US$596 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 16.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.8% and 15% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.Select Competitors (Total 13 Featured) -
- Abbott Laboratories
- Abiomed, Inc.
- Berlin Heart GmbH
- Fresenius Medical Care AG & Co. KGaA
- Getinge AB
- Jarvik Heart, Inc.
- Medtronic PLC
- ReliantHeart, Inc.
- SynCardia Systems, LLC
- Teleflex Incorporated
- Terumo Europe NV
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abiomed, Inc.
- Berlin Heart GmbH
- Fresenius Medical Care AG & Co. KGaA
- Getinge AB
- Jarvik Heart, Inc.
- Medtronic PLC
- ReliantHeart, Inc.
- SynCardia Systems, LLC
- Teleflex Incorporated
- Terumo Europe NV
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 182 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2 Billion |
Forecasted Market Value ( USD | $ 7.6 Billion |
Compound Annual Growth Rate | 18.2% |
Regions Covered | Global |